• Clasto-Lactacystin β-lactone in Viral Immunity

  2026-09-08

  Clasto-Lactacystin β-lactone is more than a standard proteasome inhibitor: it is a causal perturbation tool for testing whether protein degradation controls inflammatory cell death. This article connects its irreversible mechanism to the vIRD–RIPK3 findings in orthopoxvirus research and translates that insight into assay design.

• Ouabain Assays: Separating Pump Block from Cell Fate

  2026-09-08

  Ouabain is a selective Na+/K+-ATPase inhibitor for dissecting ion transport, calcium handling, and cellular outcomes. This guide combines mechanistic pharmacology with an assay-design framework that separates direct pump inhibition from growth arrest and cell death.

• Sinapine, PLCβ3 EF Hands, and Cardiovascular Signaling

  2026-09-07

  The reference study identifies sinapine as a PLCβ3-directed inhibitor that disrupts the Gαq–PLCβ3 interaction through the PLCβ3 EF-hand region, with Asn-260 implicated in target engagement. By focusing on a pathway-specific protein–protein interaction rather than broadly inhibiting Gαq or PLC activity, the work presents a more selective strategy for limiting RAAS-associated aldosteronism and hypertension.

• How Kinase Inhibitors Tune p38α Dephosphorylation

  2026-09-07

  The referenced bioRxiv study identifies a dual-action mechanism in which selected p38α inhibitors both block kinase activity and accelerate WIP1-mediated removal of the activation-loop phosphate. Structural comparisons connect this effect to an inhibitor-stabilized activation-loop conformation, offering a framework for interpreting kinase assays and designing more selective signaling modulators.

• MHY1485 as an mTOR Probe for Pathway Dissection

  2026-09-05

  MHY1485 is an mTOR activator that can help separate mTORC1 signaling from autophagic-flux phenotypes. This article develops a mechanistic assay framework connecting pathway readouts, autophagosome behavior, and the LMP2A–mTORC1–GCNT3 axis in nasopharyngeal carcinoma research.

• Arrb2, 6-ketoLCA, and Hepatic IRI

  2026-09-04

  The reference study identifies hepatocyte β-arrestin 2, encoded by Arrb2, as an upstream regulator of 6-ketoLCA production and macrophage polarization during hepatic ischemia–reperfusion injury. By combining clinical samples, hepatocyte-directed mouse genetics, hypoxia–reoxygenation assays, and metabolomics, it connects parenchymal signaling with immune resolution and provides a framework for mechanistic ischemia–reperfusion research.

• AT-406 (SM-406) Workflow for Cancer Research

  2026-09-04

  AT-406 (SM-406) provides a practical way to interrogate IAP-dependent survival signaling, apoptosis biomarkers, and chemotherapy response in cancer models. Its multi-IAP activity, oral bioavailability, and defined Western blot readouts support workflows ranging from mechanistic cell assays to ovarian and breast cancer xenograft studies.

• Spiroplasma Entry into Drosophila S2 Cells

  2026-09-03

  Wei and colleagues established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris enters host cells through clathrin-mediated endocytosis and macropinocytosis. Pharmacological disruption of actin filaments and microtubules reduced intracellular bacterial burden, linking cytoskeletal dynamics to pathogen uptake and intracellular infection.

• Calcitriol for Reproducible Cell Assays

  2026-09-03

  Learn how Calcitriol (SKU B2141), the active metabolite of vitamin D3, can be integrated into cell viability, proliferation, cytotoxicity, and immune-modulation workflows. This scenario-based guide covers mechanism-aware assay design, solvent handling, interpretation, and practical supplier selection.

• hUC-MSCs Target PND Through β-NGF Signaling

  2026-09-02

  This study identifies a β-NGF–TrkA–STMN2/NMNAT2–SARM1/NF-κB pathway through which human umbilical cord mesenchymal stem cells improve postoperative cognitive impairment in aged mice after tibial fracture surgery. Its combination of behavioral, pathological, proteomic, and loss-of-function experiments provides a mechanistic framework for developing cell-based interventions for perioperative neurocognitive disorders.

• Ertapenem Sodium Salt in CREC Research

  2026-09-02

  Ertapenem sodium salt provides a practical phenotypic anchor for connecting carbapenem activity with gene mobility, plasmid transmission, and clonal spread in CREC studies. This workflow-focused guide shows how to build reproducible susceptibility assays, interpret resistance mechanisms, and troubleshoot formulation or endpoint problems.

• Cy3 NHS Ester (Non-Sulfonated): Practical Guide

  2026-09-01

  Cy3 NHS ester (non-sulfonated) provides covalent orange fluorescence for labeling primary amino groups on proteins, peptides, oligonucleotides, and DNA. Its water insolubility requires an organic co-solvent, so it is best suited to workflows that tolerate DMSO or DMF rather than delicate proteins requiring an aqueous-only reagent.

• Dantrolene Sodium Salt: RyR Antagonist Guide

  2026-09-01

  Dantrolene sodium salt is a ryanodine receptor antagonist used to study calmodulin-dependent intracellular calcium release. Its reported RyR2 potency and mouse pancreatitis findings support calcium signaling experiments, while direct effects on CRISPR DNA-repair outcomes remain unestablished.

• N1-Methyl-Pseudouridine-5'-Triphosphate in mRNA

  2026-08-31

  N1-Methyl-Pseudouridine-5'-Triphosphate enables a translation-aware approach to modified RNA synthesis. This article connects N1-Methylpseudo-UTP chemistry with assay design, transcript quality control, and emerging mRNA vaccine development strategies.

• Erastin: Practical Ferroptosis Research Workflows

  2026-08-31

  Erastin is a small-molecule ferroptosis inducer for modeling oxidative, iron-dependent tumor cell death, particularly in RAS- or BRAF-altered systems. This guide translates its mechanism into reproducible dosing, orthogonal readouts, reference-informed assay design, and troubleshooting decisions for cancer biology research.

8023 records 1/535 page Next 12345 下5页 Last page